PrimeraDx Breaking News Anixa Biosciences Nabs Option to Develop Cancer Vaccines With Verdi Solutions Merck Buys Exclusive Rights to Develop Hengrui Pharma's Lp(a) Inhibitor Outside of China Ontario Brain Institute, EpiSign Partner on Rare Genetic Disorder Diagnosis Elevation Oncology Terminates CLDN18.2-Targeted ADC, Reduces Workforce Everest Medicines Cleared by FDA to Study Cancer Vaccine in US Clinical Trials Verve Therapeutics to Kick off Base-Editing Cardiovascular Drug Phase I Trial in the US
